0001062993-20-006257.txt : 20201211 0001062993-20-006257.hdr.sgml : 20201211 20201211165531 ACCESSION NUMBER: 0001062993-20-006257 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201209 FILED AS OF DATE: 20201211 DATE AS OF CHANGE: 20201211 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Smith Edward F CENTRAL INDEX KEY: 0001368350 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39267 FILM NUMBER: 201384099 MAIL ADDRESS: STREET 1: C/O POLYMEDIX, INC. STREET 2: 3701 MARKET STREET CITY: PHILADELPHIA STATE: PA ZIP: 19104 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Benitec Biopharma Inc. CENTRAL INDEX KEY: 0001808898 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: LEVEL 14, 114 WILLIAM ST CITY: MELBOURNE, VIC STATE: C3 ZIP: 3000 BUSINESS PHONE: 61(0)3 8692-7222 MAIL ADDRESS: STREET 1: LEVEL 14, 114 WILLIAM ST CITY: MELBOURNE, VIC STATE: C3 ZIP: 3000 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0306 4 2020-12-09 0001808898 Benitec Biopharma Inc. BNTC 0001368350 Smith Edward F C/O BENITEC BIOPHARMA INC. 3940 TRUST WAY HAYWARD CA 94545 1 0 0 0 Options (right to buy) 2.98 2020-12-09 4 A 0 23601 0 A 2030-12-09 Common Stock 23601 23601 D The stock options will vest in three substantially equal installments on the day prior to each of the Issuer???s next three annual stockholder meetings occurring immediately following the date of grant. /s/ Edward Smith 2020-12-11